# Metabolic Syndrome trials: 256 new since Nov 2024

Updated November 4, 2026.

256 clinical studies in Metabolic Syndrome were first posted on ClinicalTrials.gov from November 13, 2024 to November 4, 2026; 13 have an industry sponsor and 165 are recruiting or about to. The newest, NCT07917364, was posted on November 4, 2026: Asprosin and miRNA Expression in Young Women With Metabolic Syndrome (University of Applied Sciences in Nowy Targ).

## The full list

New Metabolic Syndrome clinical trials: 256 rows for $12.80, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 8 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/metabolic-syndrome

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 256
- Industry sponsored: 13
- Recruiting or not yet: 165
- Latest posted: November 4, 2026

## Newest trials

The newest 100 of 256, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07917364 | Asprosin and miRNA Expression in Young Women With Metabolic Syndrome | University of Applied Sciences in Nowy Targ | Observational | Recruiting | Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Dyslipidemias | 110 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917364) |
| November 3, 2026 | NCT07913477 | Retrospective Analysis of Erectile Dysfunction (ED) Patients Based on a Large-scale Clinical Database | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Completed | Erectile Dysfunction | 2,800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913477) |
| November 3, 2026 | NCT07912164 | Fecal Microbiota Transplantation (FMT) to Slow Biological Aging | Human Biome S.A. | Not applicable | Not yet recruiting | Aging, Healthy, Aging and Cognitive Health, Inflammation, Metabolic Syndrome, Fecal Microbiota Transplantation (FMT)... | 68 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912164) |
| October 22, 2026 | NCT07890155 | Effect of Resistance Exercises on Serum IGF-1 Levels in Knee Osteoarthritis | Sisli Hamidiye Etfal Training and Research Hospital | Not applicable | Recruiting | Osteoarthritis (Knee), Metabolic Syndrome (MetS) | 86 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890155) |
| October 22, 2026 | NCT07888894 | Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders | Uppsala University | Not applicable | Not yet recruiting | Psychoses, Metabolic Syndrome | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07888894) |
| October 7, 2026 | NCT07862712 | Assessing Trauma-related Links Between Affective and Metabolic Systems | VA Office of Research and Development | Phase 4 | Not yet recruiting | Posttraumatic Stress Disorder, Metabolic Syndrome, Insulin Resistance | 70 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862712) |
| September 25, 2026 | NCT07840807 | Traditional Chinese Medicine Fasting Therapy, Ketone Levels, and Metabolic Improvements | The Seventh Affiliated Hospital of Sun Yat-sen University | Observational | Completed | Obesity & Overweight, Diabete Type 2, Metabolic Syndrome | 1,149 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840807) |
| September 23, 2026 | NCT07836088 | A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases | Zhangzhou Municipal Hospital | Observational | Recruiting | Metabolic Syndrome, Obesity, Sarcopenia, Type 2 Diabetes | 320 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836088) |
| September 22, 2026 | NCT07833007 | Metabolic Syndrome Resposne to Dietary Limitations in Familial Mediterranean Fever in Adolescents | Cairo University | Not applicable | Recruiting | Familial Mediterranean Fever (FMF ), Metabolic Syndrome | 40 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833007) |
| September 22, 2026 | NCT07832994 | Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents | Cairo University | Not applicable | Recruiting | Celiac Disease, Metabolic Syndrome, Non Alcoholic Fatty Liver | 40 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07832994) |
| September 21, 2026 | NCT07830030 | Metabolic Status and Risk of Chronic Kidney Disease in French Overseas Populations With Morbid Obesity (OBECAMcohort). | Clinique | Observational | Active not recruiting | Morbid Obesity, Chronic Kidney Disease (Stage 3-4) | 480 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830030) |
| September 17, 2026 | NCT07824895 | Mazdutide for Weight Management and Gout in Adults With Obesity | Hongwei Jiang | Phase 4 | Not yet recruiting | Gout, Obesity (BMI\>30), Hyperuricemia, Metabolic Syndrome | 30 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824895) |
| September 16, 2026 | NCT07822763 | Preoperative Oral Carbohydrate Loading and Gastrointestinal Recovery After Bariatric Surgery in Metabolic Syndrome | First Affiliated Hospital of Chongqing Medical University | Not applicable | Recruiting | Metabolic Syndrome (MetS) | 208 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07822763) |
| September 14, 2026 | NCT07817069 | Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects | Faculty of Medicine, Sousse | Not applicable | Recruiting | Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal Obesity | 30 | Tunisia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817069) |
| September 9, 2026 | NCT07808619 | Longevity Metrics AI/ML Development Study | Longevity Metrics, Inc. | Observational | Recruiting | Aging, Mortality, Cardiovascular Disease Prevention, Metabolic Syndrome, Cognitive Dysfunction, Frailty... | 1,000,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808619) |
| September 8, 2026 | NCT07806279 | Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk | Uppsala University | Phase 3 | Not yet recruiting | Cardiometabolic Syndrome, Obesity and Cardiovascular Risk, Overweight , Obesity | 250 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806279) |
| September 4, 2026 | NCT07804680 | This Study Will Evaluate Cardiorespiratory and Muscular Fitness to Examine Associations With Anthropometric Characteristics and Other... | University of Virginia | Observational | Recruiting | Autism Spectrum Disorder (ASD), Cardiometabolic Health Indicators, Cardiometabolic Risk Factors, Metabolic Syndrome... | 200 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804680) |
| September 1, 2026 | NCT07797036 | Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus | University of Massachusetts, Worcester | Phase 2/3 | Not yet recruiting | Gestational Diabetes Mellitus (GDM), Metabolic Syndrome | 226 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797036) |
| August 31, 2026 | NCT07793747 | Serum Asprosin, Metabolic Syndrome, and Cardiometabolic Risk in Rheumatoid Arthritis | Assiut University | Observational | Not yet recruiting | Rheumatoid Arthritis, Metabolic Syndrome, Cardiovascular Diseases | 75 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793747) |
| August 28, 2026 | NCT07793487 | Applications of a Functional Dairy Product in Diet Therapy | Warsaw University of Life Sciences | Not applicable | Enrolling by invitation | Metabolic Syndrome, IBS - Irritable Bowel Syndrome | 80 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07793487) |
| August 25, 2026 | NCT07785518 | Prevalenza Della Insulino Resistenza e Correlate Malattie Cardiovascolari Nella città di Napoli | Comune di Napoli | Observational | Completed | Insulin Resistance Syndrome, Cardio Vascular Disease, Prevalence | 123,752 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785518) |
| August 21, 2026 | NCT07780253 | Creatinine-Body Weight Ratio as a Predictor of Hepatic Steatosis in Patients With Metabolic Syndrome | Assiut University | Observational | Not yet recruiting | Metabolic Syndrome (MetS) | 96 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780253) |
| August 18, 2026 | NCT07770282 | Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome | All India Institute of Medical Sciences, Bhubaneswar | Phase 3 | Not yet recruiting | Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance | 600 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770282) |
| August 17, 2026 | NCT07766928 | Lipid and Glucose Response to Plant-based and Regular Burgers | University of Saskatchewan | Not applicable | Not yet recruiting | Metabolic Syndrome | 10 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07766928) |
| August 13, 2026 | NCT07763626 | Gdue Plus a Hypocaloric Mediterranean Diet in Adults With MASLD | University of Genova | Not applicable | Completed | Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Syndrome | 112 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763626) |
| August 12, 2026 | NCT07759674 | Relationship Between Metformin Treatment, Anemia, and Erythropoietin Levels in Women With Polycystic Ovary Syndrome in Jordan | Jerash Private University | Phase 4 | Completed | Polycystic Ovary Syndrome (PCOS) Women, Insulin Resistance Syndrome | 25 | Jordan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759674) |
| August 12, 2026 | NCT07759323 | Polygonatum Sibiricum Reduces Visceral Fat in Obese Adults | Zhejiang Provincial Tongde Hospital | Not applicable | Not yet recruiting | Visceral Obesity, Metabolic Syndrome | 66 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759323) |
| August 11, 2026 | NCT07758842 | Lifestyle Modification for Erectile Dysfunction in Men With Metabolic Syndrome | Al-Azhar University | Not applicable | Recruiting | Erectile Dysfunction, Metabolic Syndrome | 55 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07758842) |
| July 31, 2026 | NCT07739602 | Effects of Cornelian Cherry Supplementation in Patients With Metabolic Syndrome | Wroclaw Medical University | Not applicable | Completed | Metabolic Syndrome | 55 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739602) |
| July 30, 2026 | NCT07737340 | Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR) | Yaşar Bayındır, MD | Observational | Recruiting | HIV Infections, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH), Fatty Liver | 411 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737340) |
| July 28, 2026 | NCT07731373 | Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) | Kayseri City Hospital | Observational | Not yet recruiting | Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity... | 150 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731373) |
| July 28, 2026 | NCT07731360 | Non-Invasive Diagnostic Panel for MASLD in Children With Obesity | Kayseri City Hospital | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity, Insulin Resistance Syndrome | 180 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731360) |
| July 27, 2026 | NCT07728669 | Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy | Kazakh Academy of Nutrition | Not applicable | Recruiting | Type 2 Diabetes Mellitus (T2DM), Obesity (Disorder), Overweight, Metabolic Syndrome | 120 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728669) |
| July 17, 2026 | NCT07710274 | Effectiveness of the Personalized Responses & Integrated Systems for Metabolism (PRISM) on Improving Insulin Resistance Among Adults With... | National University Health System, Singapore | Not applicable | Recruiting | Metabolic Syndrome (MetS) | 200 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710274) |
| July 16, 2026 | NCT07707778 | Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV | National Taiwan University Clinical Trial Center | Phase 4 | Enrolling by invitation | Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease, Dyslipidaemia, Diabetes... | 60 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707778) |
| July 15, 2026 | NCT07704749 | Fitbit-Tracked Micromovement for Cardiometabolic Health in Rural Women | Texas Tech University Health Sciences Center | Not applicable | Not yet recruiting | Cardiometabolic Risk Factors | 125 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07704749) |
| July 14, 2026 | NCT07703371 | Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome | JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH | Not applicable | Recruiting | Obesity & Overweight, Metabolic Syndrome, Gut Dysbiosis, Insulin Resistance, Dyslipidemia | 50 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07703371) |
| July 14, 2026 | NCT07702695 | A Mediterranean Diet-Based Culinary Intervention in Adults With Metabolic Syndrome | Fundacion Clinic per a la Recerca Biomédica | Not applicable | Not yet recruiting | Metabolic Syndrome | 120 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702695) |
| July 14, 2026 | NCT07702669 | Modified Huanglian Wendan Decoction for Metabolic Syndrome | First Affiliated Hospital of Heilongjiang Chinese Medicine University | Not applicable | Completed | Metabolic Syndrome | 180 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702669) |
| July 14, 2026 | NCT07702123 | Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease | Cairo University | Not applicable | Recruiting | Metabolic Syndrome, Behcet Disease | 40 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702123) |
| July 13, 2026 | NCT07697469 | Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization | Grigore T. Popa University of Medicine and Pharmacy | Observational | Not yet recruiting | Cardiovascular-Kidney-Metabolic Syndrome, Atrial Cardiomyopathy, Atrial Fibrillation, Chronic Kidney Disease, Metabolic... | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697469) |
| July 10, 2026 | NCT07696247 | Effect of Agave Inulin Supplementation on Metabolic Profile and Intestinal Abundance of Bifidobacterium and Lactobacillaceae in Adults With... | Universidad Autonoma de Queretaro | Not applicable | Active not recruiting | Type 2 Diabetes, Gut Microbiota, Insulin Resistance, Metabolic Syndrome, Prebiotic | 43 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07696247) |
| July 7, 2026 | NCT07688694 | Development of Anti-Diabetic Nutraceuticals From Legume Seed Coats | JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH | Not applicable | Enrolling by invitation | Postprandial Hyperglycemia, Type 2 Diabetes, Metabolic Syndromes | 100 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07688694) |
| June 30, 2026 | NCT07675122 | Duodenal-jejunal Bypass Sleeve (DJBS) for Obesity and Metabolic Syndrome | Chinese University of Hong Kong | Not applicable | Recruiting | Obesity, Metabolic Syndrome (MetS) | 20 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675122) |
| June 25, 2026 | NCT07669168 | Health Ahead Comparative Effectiveness Study | William Brandenburg, MD | Not applicable | Recruiting | Health Services Accessibility, Rural Health, Medically Underserved Area, Preventive Health Services, Patient... | 1,000,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669168) |
| June 22, 2026 | NCT07659444 | Metformin Withdrawal In Metabolic Syndrome | University of Castilla-La Mancha | Not applicable | Active not recruiting | Metabolic Syndrome (MetS), Glucose Intolerance | 21 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07659444) |
| June 17, 2026 | NCT07653048 | Personality Traits and Biochemical Risk Phenotypes | Medical Center TOPMED | Observational | Recruiting | Prediabetes, Hyperglycemia, Metabolic Syndrome | 1,000 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653048) |
| June 16, 2026 | NCT07651462 | Preoperative Fasting and the Gut Microbiome Before Hip Replacement | Charite University, Berlin, Germany | Not applicable | Recruiting | Hip Osteoarthritis, Arthroplasty, Replacement, Hip, Postoperative Complications, Surgical Wound Infection... | 130 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651462) |
| June 16, 2026 | NCT07651202 | H. Pylori Infection and Metabolic Syndrome: A Retrospective Cross-Sectional Study | Nanjing First Hospital, Nanjing Medical University | Observational | Completed | HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome | 5,218 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07651202) |
| June 15, 2026 | NCT07646782 | Human Observatory Study | Longevity Metrics, Inc. | Observational | Recruiting | Aging, Mortality, All-cause Mortality, Life Expectancy, Cardiovascular Diseases, Neoplasms, Cognitive Dysfunction... | 1,000,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646782) |
| June 12, 2026 | NCT07645105 | Body Weight Reduction and Metabolic/Biochemical Parameters in Overweight or Obesity | Medical University of Silesia | Observational | Completed | Overweight , Obesity, Abdominal Obesity-Metabolic Syndrome | 53 | Poland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645105) |
| June 11, 2026 | NCT07643675 | Glycine Supplementation Improves Cognitive Performance in Mexican Older Adults | Brenda Sarahí Beristain Lujano | Not applicable | Completed | Older Adults With Cognitive Decline, Insulin Resistance Syndrome, Aging | 59 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643675) |
| June 11, 2026 | NCT07643376 | Evaluation of Metabolic Parameters, Intestinal Permeability and Gastrointestinal Symptoms After Bariatric Surgery in Body Weight Management | Toros University | Observational | Not yet recruiting | Obesity, Morbid, Bariatric Surgery, Intestinal Permeability, Gastrointestinal Symptoms, Metabolic Syndrome | 40 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643376) |
| June 10, 2026 | NCT07638111 | SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to... | Hospices Civils de Lyon | Not applicable | Not yet recruiting | Obesity & Overweight, Insulin Resistance Syndrome | 20 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638111) |
| June 4, 2026 | NCT07627555 | Polyunsaturated Fatty Acids-based Bars Effect on Metabolic Syndrome Patients | University of Lahore | Not applicable | Completed | Dyslipidemia, Metabolic Syndrome (MetS) | 60 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627555) |
| June 4, 2026 | NCT07625332 | Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) | Northwell Health | Phase 2/3 | Recruiting | Spinal Cord Injury, Traumatic Spinal Cord Injury, Paraplegia and Tetraplegia, Metabolic Syndrome | 60 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625332) |
| June 2, 2026 | NCT07621640 | Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study) | Hallym University | Not applicable | Not yet recruiting | Obesity, Metabolic Syndrome, Brown Adipose Tissue | 80 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621640) |
| June 2, 2026 | NCT07620886 | Effects of Postprandial Walking and Resistance Snacking on Glucose Responses in Adults With Metabolic Syndrome | Seoul National University | Not applicable | Not yet recruiting | Metabolic Syndrome, Prediabetes | 25 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620886) |
| June 1, 2026 | NCT07616570 | Serum Adipokines and Metabolic Parameters With Hormone Replacement in Newly Diagnosed Hypothyroidism | Başakşehir Çam & Sakura City Hospital | Observational | Completed | Hypothyroidism, Primary Hypothyroidism, Metabolic Syndrome | 88 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616570) |
| May 26, 2026 | NCT07606872 | Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes | Salah Snouda | Not applicable | Enrolling by invitation | Type 2 Diabetes Mellitus (T2DM), Insulin Resistance, Metabolic Syndrome | 150 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606872) |
| May 26, 2026 | NCT07606014 | No Guts No Glory Probiotics | University Medical Center Groningen | Phase 2/3 | Recruiting | Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine | 112 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606014) |
| May 15, 2026 | NCT07590713 | Effect of Korean Ginseng Extract on Fatigue | University of Taipei | Not applicable | Completed | Obesity & Overweight, Metabolic Syndrome | 60 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590713) |
| May 15, 2026 | NCT07589374 | Cf-PWV and TyG Index Study | Hospital de Base | Observational | Not yet recruiting | Hypertension, Insulin Resistance Syndrome, Arterial Stiffness, Cardiovascular Risk, Blood Pressure Variability | 800 | Brazil | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589374) |
| May 15, 2026 | NCT07589322 | Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs | Tri-Service General Hospital (TSGH) | Not applicable | Recruiting | Obesity and Metabolic Syndrome | 120 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589322) |
| May 14, 2026 | NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 160 | Paraguay | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588438) |
| May 13, 2026 | NCT07584330 | AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults | Zhujiang Hospital | Observational | Recruiting | Overweight and Obesity, Diabetes Mellitus, Type 2, Prediabetic State, Metabolic Syndrome | 2,800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584330) |
| May 7, 2026 | NCT07574333 | Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including Elderly | National Medical Research Center for Therapy and Preventive Medicine | Not applicable | Recruiting | Type 2 Diabetes Mellitus (T2DM), Hyperglycemia, Metabolic Syndrome, Older Adults (65 Years and Older) | 250 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07574333) |
| May 5, 2026 | NCT07567378 | CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational... | JULIO GRANADOS MONTIEL | Observational | Not yet recruiting | Psoriatic Arthritis, Osteoarthitis, Knee, Diabetes (DM), Type 2 Diabetes Mellitus (T2DM), Obesity (Disorder), Insulin... | 30 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567378) |
| May 4, 2026 | NCT07563777 | 100-Year Human Aging Study | Longevity Metrics, Inc. | Observational | Recruiting | Aging, Aging Well, All-Cause Mortality, Mortality, Metabolic Syndrome, Cardiovascular Diseases, Cognitive Dysfunction... | 1,000,000 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563777) |
| May 4, 2026 | NCT07563764 | Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome | KMUHIRB-F(I)-20230051 | Not applicable | Recruiting | Bladder, Lower Urinary Track Symptoms, Metabolic Syndrome, Urgency-Frequency, Bladder, Overactive | 60 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563764) |
| May 4, 2026 | NCT07563647 | Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With... | Kafrelsheikh University | Phase 4 | Completed | Erectile Dysfunction, Left Ventricular Diastolic Dysfunction, Metabolic Syndrome | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07563647) |
| April 30, 2026 | NCT07560059 | Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV) | Algerian Society of Diabetology | Observational | Completed | Diabetes Mellitus, COVID-19, Post-Acute COVID-19 Syndrome | 201 | Algeria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560059) |
| April 28, 2026 | NCT07554326 | Rise & Thrive: Community-Engagement Intervention for Stress and Depression in Youth. | Ann & Robert H Lurie Children's Hospital of Chicago | Not applicable | Recruiting | Depressive Symptoms, Allostatic Load, Metabolic Syndrome | 300 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554326) |
| April 27, 2026 | NCT07551960 | Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA) | Nemocnice AGEL Trinec-Podlesi a.s. | Not applicable | Enrolling by invitation | Cardiovascular Risk Factors, Insulin Resistance, Obesity, Dyslipidemias, Metabolic Syndrome | 100 | Czechia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551960) |
| April 21, 2026 | NCT07541898 | Effects of Berberine on Cardiometabolic Outcomes | University of Central Lancashire | Not applicable | Not yet recruiting | Cardiometabolic Syndrome | 40 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07541898) |
| April 21, 2026 | NCT07540949 | Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity | National Taiwan Sport University | Not applicable | Recruiting | Obesity, Metabolic Syndrome | 40 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540949) |
| April 17, 2026 | NCT07535333 | Exercise-Targeted Smart Lifestyle Management | China National Center for Cardiovascular Diseases | Not applicable | Not yet recruiting | M-health, Metabolic Syndrome, Lifestyle Alteration, Lifestyle (Sedentary Behavior and Physical Activity), Overweight... | 435 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07535333) |
| April 16, 2026 | NCT07533513 | Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism | Sun Yat-sen University | Not applicable | Not yet recruiting | Metabolic Syndrome (MetS), Metabolic Syndrome Risk Factors | 20 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533513) |
| April 13, 2026 | NCT07523971 | Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study | JW Pharmaceutical | Observational | Recruiting | Dyslipidemias | 10,000 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523971) |
| April 1, 2026 | NCT07505745 | MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity | Hudson Biotech | Phase 2 | Recruiting | Prediabetes, Insulin Resistance, Overweight/Obesity | 120 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505745) |
| April 1, 2026 | NCT07505277 | Study of the Effects of Food Formulations Containing Antioxidants, Prebiotic Fibers, and Oat Beta-glucans in Individuals at Risk of... | Dr. Schär AG / SPA | Not applicable | Recruiting | Metabolic Syndrome | 40 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07505277) |
| March 30, 2026 | NCT07501858 | Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metabolic Syndrome | Center of New Medical Technologies | Observational | Recruiting | Metabolic Syndrome | 100 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501858) |
| March 25, 2026 | NCT07491978 | Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment | Tarumanagara University | Observational | Not yet recruiting | Metabolic Syndrome, Hypertension, Diabetes (DM), Tachycardia, ASCVD, Depression Disorder, Anxiety, Stress (Psychology)... | 1,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07491978) |
| March 23, 2026 | NCT07487571 | MPV as a Predictor for ACS in Patients With MASLD | Sohag University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Acute Coronary Syndromes (ACS) | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07487571) |
| March 16, 2026 | NCT07474233 | Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health | Liverpool John Moores University | Observational | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction | 90 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474233) |
| March 11, 2026 | NCT07463417 | Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women | Sarah Wragge Wellness | Not applicable | Completed | Metabolic Syndrome, Obesity & Overweight, Blood Glucose Monitoring, Type 2 Diabetes Prevention | 85 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463417) |
| March 10, 2026 | NCT07462871 | Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health | Liverpool John Moores University | Not applicable | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia | 30 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462871) |
| March 10, 2026 | NCT07462104 | Metabolic Syndrome Associated Diet | Recep Tayyip Erdogan University Training and Research Hospital | Observational | Not yet recruiting | Metabolic Syndrome (MetS), Periodontitis, Diet, Food and Nutrition | 100 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462104) |
| March 10, 2026 | NCT07460856 | Effects of Cranberry on Gut and Metabolic Health | Laval University | Not applicable | Recruiting | Overweight/Obesity, Metabolic Syndrome, Insulin Resistance, Microbiota | 73 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07460856) |
| March 3, 2026 | NCT07446218 | Pharmacist-led Interventions in Psychiatric Patients | University of Lahore | Not applicable | Not yet recruiting | Mental Disorders, Metabolic Syndrome | 148 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07446218) |
| February 24, 2026 | NCT07431593 | Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications | University of Rijeka | Observational | Recruiting | Overweight and Obesity, Inflammation, Metabolic Syndrome | 200 | Croatia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07431593) |
| February 24, 2026 | NCT07430839 | Exercise and Carotid Artery Function in Metabolic Syndrome | University of Wisconsin, Madison | Observational | Recruiting | Metabolic Syndrome | 48 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07430839) |
| February 23, 2026 | NCT07426172 | Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism. | Ricardo Mora | Not applicable | Recruiting | Hyperlactatemia, Metabolic Syndrome (MetS), Lipolysis, Exercise | 24 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07426172) |
| February 17, 2026 | NCT07415720 | Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention. | Clinica Universidad de Navarra, Universidad de Navarra | Not applicable | Recruiting | Diabete Type 2, Obesity & Overweight, Insulin Resistance Syndrome | 150 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415720) |
| February 13, 2026 | NCT07411222 | Emotional Eating, Sleep Quality, Mental State and Metabolic Syndrome | Abant Izzet Baysal University | Observational | Recruiting | Schizophrenia, Bipolar Disorder, Psychiatric Issue, Metabolic Syndrome, Emotional Eating, Sleep, Mediating | 78 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07411222) |
| February 13, 2026 | NCT07410325 | Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program... | National University Health System, Singapore | Not applicable | Recruiting | Metabolic Syndrome (MetS), Metabolic Syndrome | 316 | Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07410325) |
| February 12, 2026 | NCT07406191 | WB-EMS Effects on Cardiometabolic Risk Factors | University of Erlangen-Nürnberg Medical School | Not applicable | Active not recruiting | Hypertension, Metabolic Syndrome, Hypercholesterolemia, Hypertriglyceridemia, Overweight and Obesity | 28 | Germany | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07406191) |
| February 11, 2026 | NCT07401888 | A Study Of Milk Consumption In Metabolic Syndrome | Mayo Clinic | Not applicable | Recruiting | Metabolic Syndrome | 40 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07401888) |
| February 10, 2026 | NCT07399600 | Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease | The Affiliated Hospital of Hangzhou Normal University | Not applicable | Not yet recruiting | Liver Diseases, Alcoholic, Fatty Liver, Metabolic Syndrome | 105 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07399600) |
| February 9, 2026 | NCT07396792 | Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram | I.M. Sechenov First Moscow State Medical University | Observational | Not yet recruiting | Arterial Hypertension, Heart Rhythm Disorders, Valvular Heart Diseases, Heart Failure, Diabetes Mellitus, Chronic... | 4,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07396792) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Cairo University | 8 | September 22, 2026 |
| Assiut University | 4 | August 31, 2026 |
| University of Lahore | 4 | June 4, 2026 |
| Longevity Metrics, Inc. | 3 | September 9, 2026 |
| Chinese University of Hong Kong | 3 | June 30, 2026 |
| National Taiwan University Hospital | 3 | November 24, 2025 |
| Jagiellonian University | 3 | January 27, 2025 |
| Uppsala University | 2 | October 22, 2026 |
| Kayseri City Hospital | 2 | July 28, 2026 |
| National University Health System, Singapore | 2 | July 17, 2026 |
| JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH | 2 | July 14, 2026 |
| Charite University, Berlin, Germany | 2 | June 16, 2026 |
| Nanjing First Hospital, Nanjing Medical University | 2 | June 16, 2026 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 2 | April 28, 2026 |
| University of Central Lancashire | 2 | April 21, 2026 |
| Liverpool John Moores University | 2 | March 16, 2026 |
| Recep Tayyip Erdogan University Training and Research Hospital | 2 | March 10, 2026 |
| University of Wisconsin, Madison | 2 | February 24, 2026 |
| University of Erlangen-Nürnberg Medical School | 2 | February 12, 2026 |
| I.M. Sechenov First Moscow State Medical University | 2 | February 9, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 143 | November 3, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 83 | November 4, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 11 | October 7, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 6 | April 1, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 5 | September 8, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 3 | September 1, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 3 | October 20, 2025 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 2 | February 4, 2025 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 37 | October 7, 2026 |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 27 | November 3, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 18 | October 22, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 15 | September 22, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 14 | July 14, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 13 | August 25, 2026 |
| [Poland](https://specstream.ai/data/clinical-trials/country/poland) | 12 | November 4, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 12 | July 16, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 7 | July 10, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 6 | June 30, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 6 | June 4, 2026 |
| [United Kingdom](https://specstream.ai/data/clinical-trials/country/united-kingdom) | 5 | May 26, 2026 |
| [Brazil](https://specstream.ai/data/clinical-trials/country/brazil) | 5 | May 15, 2026 |
| [Sweden](https://specstream.ai/data/clinical-trials/country/sweden) | 4 | September 8, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 4 | August 17, 2026 |
| [Singapore](https://specstream.ai/data/clinical-trials/country/singapore) | 3 | July 17, 2026 |
| [India](https://specstream.ai/data/clinical-trials/country/india) | 3 | July 14, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 3 | June 16, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 3 | May 26, 2026 |
| [Russia](https://specstream.ai/data/clinical-trials/country/russia) | 3 | May 7, 2026 |
| [Croatia](https://specstream.ai/data/clinical-trials/country/croatia) | 3 | February 24, 2026 |
| [Jordan](https://specstream.ai/data/clinical-trials/country/jordan) | 2 | August 12, 2026 |
| [Romania](https://specstream.ai/data/clinical-trials/country/romania) | 2 | July 13, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 2 | June 10, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 2 | June 2, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).